Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE

Open source

DOI: 10.1067/mai.2000.110798
Published: 2000 Nov
Container: The Journal of allergy and clinical immunology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1067/mai.2000.110798,
  title = {Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.},
  author = {Fish JE and Karpel JP and Craig TJ and Bensch GW and Noonan M and Webb DR and Silverman B and Schenkel EJ and Rooklin AR and Ramsdell JW and Nathan R and Leflein JG and Grossman J and Graft DF and Gower RG and Garay SM and Frigas E and Degraff AC and Bronsky EA and Bernstein DI and Berger W and Shneyer L and Nolop KB and Harrison JE},
  year = {2000},
  journal = {The Journal of allergy and clinical immunology},
  doi = {10.1067/mai.2000.110798},
  url = {https://doi.org/10.1067/mai.2000.110798}
}

RIS

TY  - JOUR
TI  - Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
AU  - Fish JE
AU  - Karpel JP
AU  - Craig TJ
AU  - Bensch GW
AU  - Noonan M
AU  - Webb DR
AU  - Silverman B
AU  - Schenkel EJ
AU  - Rooklin AR
AU  - Ramsdell JW
AU  - Nathan R
AU  - Leflein JG
AU  - Grossman J
AU  - Graft DF
AU  - Gower RG
AU  - Garay SM
AU  - Frigas E
AU  - Degraff AC
AU  - Bronsky EA
AU  - Bernstein DI
AU  - Berger W
AU  - Shneyer L
AU  - Nolop KB
AU  - Harrison JE
PY  - 2000
JO  - The Journal of allergy and clinical immunology
DO  - 10.1067/mai.2000.110798
UR  - https://doi.org/10.1067/mai.2000.110798
ER  -

APA

JE, F., JP, K., TJ, C., GW, B., M, N., DR, W., B, S., EJ, S., AR, R., JW, R., R, N., JG, L., J, G., DF, G., RG, G., SM, G., E, F., AC, D., EA, B., DI, B., W, B., L, S., KB, N., & JE, H. (2000). Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.. The Journal of allergy and clinical immunology. https://doi.org/10.1067/mai.2000.110798

Source records

pubmed · retrieved 2026-09-24T19:02:09.852Z